Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails

European Journal of Pharmacology

Volumn 554, Issue 2-3, 2007, Pages 191-195

  He, Shu Ying ^a   Qian, Zhi Yu ^a   Wen, Na ^a   Tang, Fu Tian ^b   Xu, Guang Lin ^c   Zhou, Cheng Hua ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c NANJING NORMAL UNIVERSITY   (China)

Author keywords

(Quail); Atherosclerosis; Crocetin; Lipids; Malondialdehyde; Nitric oxide

Indexed keywords

ANTILIPEMIC AGENT; CROCETIN; EOSIN; HEMATOXYLIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MEVINOLIN; NITRIC OXIDE; TRIACYLGLYCEROL; ZHIBITUO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; FEEDING; HISTOPATHOLOGY; HYPERLIPIDEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; QUAIL; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; AORTA; ATHEROSCLEROSIS; CAROTENOIDS; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DIET, ATHEROGENIC; DIETARY FATS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPIDS; MALE; MALONDIALDEHYDE; MOLECULAR STRUCTURE; NITRIC OXIDE; QUAIL; TRIGLYCERIDES;

EID: 33845326109     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.09.071     Document Type: Article

References (17)

1. Blantz R.C., Lortie M., Valton V., Gabbai F.B., Palmer R.J., and Thompson S. Activities of nitric oxide in normal physiology and uremia. Semin. Nephrol. 16 (1996) 144-150
2. Cushing S.D., Berliner J.A., Valente A.J., Territo M.C., Navab M., Parhami F., Gerrity R.G., Schwartz C.J., and Fogelman A.M. Minimally modified low-density lipoprotein induces monocyte-chemotactic protein-1 in human endothelial cells and SMC. Proc. Natl. Acad. Sci. 87 (1990) 5134-5138
3. He S., Qian Z., Tang F., Wen N., Xu G., and Sheng L. Effect of crocin on experimental atherosclerosis in quails and its mechanism. Life Sci. 77 (2005) 907-921
4. Herttuala S., Palinski W., Butler S.W., Picard S., Steinberg D., and Witztum J.L. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14 (1994) 32-40
5. Hessler J.R., Robertson A.L.J., and Chisolm G.M. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32 (1979) 213-229
6. Holvoet P., and Collen D. β-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2376-2382
7. Lusis A.J., and Navab M. Lipoprotein oxidation and gene expression in the artery wall: new opportunities for pharmacological intervention in atherosclerosis. Biochem. Pharmacol. 46 (1993) 2119-2126
8. Palinski W., Rosenfeld M.E., Yla-Herttuala S., Gurther G.C., Socher S.A., Butler S.W., Parthasarathy S., Carew T.E., Steinberg D., and Witztum J.L. Low-density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. 86 (1989) 1372-1376
9. Parthasarathy S., Printz D.J., Boyd D., Joy L., and Steinberg D. Macrophage oxidation of low-density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 6 (1986) 505-510
10. Radomski M.W., Palmer R.M., and Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. 87 (1990) 5193-5197
11. Rosenson R.S. Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis 173 (2004) 1-12
12. Ross R. The pathogenesis of atherosclerosis: a perspective for 1990s. Nature 362 (1993) 801-809
13. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol: modification of low-density lipoproteins that increase its atherogenicity. N. Engl. J. Med. 320 (1989) 915-924
14. Wu Y.J., Hong C.Y., Lin S.J., Paulin W., and Shiao M.S. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 481-486
15. Yaoxian D., and Nosratola D.V. Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension 32 (1998) 718-723
16. Zhang J.T. Modern Experimental Methods in Pharmacology. third ed. (1998), Beijing Medical University, Beijing 1266-1267
17. Zheng S., Qian Z., Tang F., and Sheng L. Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits. Biochem. Pharmacol. 70 (2005) 1192-1199